Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir in Genotype 1/2 Chronic Hepatitis C With Depression
NCT01753570Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Dec 2012
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of telaprevir in hepatitis C (HCV), sponsored by Mitsubishi Tanabe Pharma. Started Dec 2012; status: completed.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01753570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01753570.